EinzigMed

EinzigMed is a digital platform for the ordering, coordination, and clinical logistics of autologous CAR T-cell therapies, a vital class of advanced therapy medicinal products with established use in oncology and expanding potential in areas such as neuroscience and immunology. It harmonizes multiple manufacturers’ systems, integrating fragmented back-end processes into a coherent, interoperable workflow that enables healthcare professionals to manage the patient journey from enrollment through therapy ordering, apheresis scheduling, and treatment delivery. By streamlining these operational steps, EinzigMed reduces bottlenecks and ensures timely, reliable access to personalized therapies. The platform directly supports the scalable implementation of ATMPs across Europe, providing particular advantages for regions with limited digital infrastructure or innovation capacity. By connecting biotechnological innovation with real-world clinical practice, EinzigMed facilitates broader adoption of advanced therapies and allows clinicians to focus on delivering the right treatment to the right patient efficiently and effectively.